Wadih Arap is the Director of the Rutgers Cancer Institute of New Jersey at University Hospital and Chief, Division of Hematology/Oncology in the Department of Medicine at Rutgers New Jersey Medical School. He has served on the National Cancer Institute’s Board of Scientific Counselors, several review boards for the National Institutes of Health and the U.S. Department of Defense’s Prostate and Breast Cancer Research Program. His research is based on the premise that differential protein expression in disease tissues enables the development of novel, targeted drugs to treat human disease. By integrating genomic analyses and analytical high-throughput technology, functional protein-protein interactions can be manipulated to develop clinical strategies for effective disease management.